Open Access
Numéro
Med Sci (Paris)
Volume 41, Numéro 2, Février 2025
Page(s) 133 - 135
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2025008
Publié en ligne 3 mars 2025
  1. Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet 2024 ; 25 : 184–95. [CrossRef] [PubMed] [Google Scholar]
  2. El Masri R, Delon J. RHO GTPases: from new partners to complex immune syndromes. Nat Rev Immunol 2021 ; 21 : 499–513. [CrossRef] [PubMed] [Google Scholar]
  3. Donkó A, Sharapova SO, Kabat J, et al. Clinical and functional spectrum of RAC2-related immunodeficiency. Blood 2024 ; 143 : 1476–87. [CrossRef] [PubMed] [Google Scholar]
  4. Arrington ME, Temple B, Schaefer A, Campbell SL. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2. J Biol Chem 2020 ; 295 : 12130–42. [CrossRef] [PubMed] [Google Scholar]
  5. Doye A, Chaintreuil P, Lagresle-Peyrou C, et al. RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation. J Exp Med 2024 ; 221 : e20231562. [CrossRef] [PubMed] [Google Scholar]
  6. Ridley AJ. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006 ; 16 : 522–529. [CrossRef] [PubMed] [Google Scholar]
  7. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002 ; 420 : 629–35. [CrossRef] [PubMed] [Google Scholar]
  8. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005 ; 15 : 163–71. [CrossRef] [PubMed] [Google Scholar]
  9. Boquet P, Lemichez E. Bacterial virulence factors targeting Rho GTPases: parasitism or symbiosis? Trends Cell Biol 2003 ; 13 : 238–46. [CrossRef] [PubMed] [Google Scholar]
  10. Stern H, Donkó A, Shapiro T, et al. A novel RAC2 variant presenting as severe combined immunodeficiency. J Clin Immunol 2021 ; 41 : 473–6. [CrossRef] [PubMed] [Google Scholar]
  11. Flatau G, Lemichez E, Gauthier M, et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997 ; 387 : 729–33. [CrossRef] [PubMed] [Google Scholar]
  12. Lerm M, Selzer J, Hoffmeyer A, et al. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 1999 ; 67 : 496–503. [CrossRef] [PubMed] [Google Scholar]
  13. Boyer L, Magoc L, Dejardin S, et al. Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway. Immunity 2011 ; 35 : 536–49. [CrossRef] [PubMed] [Google Scholar]
  14. Dufies O, Doye A, Courjon J, et al. Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in mice. Nat Microbiol 2021 ; 6 : 401–12. [CrossRef] [PubMed] [Google Scholar]
  15. Dufies O, Boyer L. RhoGTPases and inflammasomes: Guardians of effector-triggered immunity. PLoS Pathog 2021 ; 17 : e1009504. [CrossRef] [PubMed] [Google Scholar]
  16. Shao F. Gasdermins: making pores for pyroptosis. Nat Rev Immunol 2021 ; 21 : 620–1. [CrossRef] [PubMed] [Google Scholar]
  17. Fu J, Schroder K, Wu H. Mechanistic insights from inflammasome structures. Nat Rev Immunol 2024 ; 24 : 518–35. [CrossRef] [PubMed] [Google Scholar]
  18. Kayagaki N, Kornfeld OS, Lee BL, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 2021 ; 591 : 131–6. [CrossRef] [PubMed] [Google Scholar]
  19. Nishitani-Isa M, Mukai K, Honda Y, et al. Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation. J Exp Med 2022 ; 219 : e20211889. [CrossRef] [PubMed] [Google Scholar]
  20. Spel L, Zaffalon L, Hou C, et al. CDC42 regulates PYRIN inflammasome assembly. Cell Rep 2022 ; 41 : 111636. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.